| Class 2 Device Recall Clinical Chemistry Total Bilirubin | |
Date Initiated by Firm | July 09, 2009 |
Date Posted | April 16, 2012 |
Recall Status1 |
Terminated 3 on March 07, 2014 |
Recall Number | Z-1425-2012 |
Recall Event ID |
52748 |
510(K)Number | K022339 |
Product Classification |
Diazo colorimetry, bilirubin - Product Code CIG
|
Product | Clinical Chemistry Total Bilirubin, 6L45-20 and 6L45-40.
Used for the quantitative analysis of total bilirubin in human serum or plasma of adults and neonates. |
Code Information |
List Numbers: 6L45-20, 6L45-40 Lot Numbers: 64047HW00, 64048HW00, 65084HW00, 65088HW00, 69001HW00, 69002HW00, 72016HW00, 73038HW00, 73057HW00, 75036HW00, 76023HW00, 77014HW00, 69025HW00, 73015HW00, 76038HW00, 77015HW00. |
Recalling Firm/ Manufacturer |
Abbott Laboratories Inc. 820 Mission St South Pasadena CA 91030-3142
|
For Additional Information Contact | 626-440-0705 |
Manufacturer Reason for Recall | Abbott Laboratories has issued a recall on the Clinical Chemistry Total Bilirubin due to an under-recovery on one clinical neonatal specimen resulting in a value less than the assay linear limit. |
FDA Determined Cause 2 | Material/Component Contamination |
Action | Abbott Laboratories plans to release a Product Correction letter to customers instructing customers to follow the steps provided in order to revise their Total Bilirubin assay parameters. The letter explained the reason for the recall, along with the patient impact. Customers were to keep the letter as part of their laboratory records and also forward a copy to any other laboratories that they may have forwarded Total Bilirubin kits. U.S. Customers should contact Customer Service at 1-877-4ABBOTT, if they have questions. |
Quantity in Commerce | 11,282 |
Distribution | Worldwide Distribution -- USA, Guatemala, Chile, Brazil, Canada, Germany, Hong Kong, Thailand, Puerto Rico, Australia, New Zealand, Trinidad & Tobago, Bermuda, Curacao, Cayman Island, and Jamaica. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = CIG
|
|
|
|